New pill aims to fight daytime sleepiness in narcolepsy
NCT ID NCT07502443
First seen Apr 01, 2026 · Last updated May 05, 2026 · Updated 6 times
Summary
This study tests a new medication called ALKS 2680 to see if it can reduce daytime sleepiness and other symptoms in adults with narcolepsy type 2. About 176 participants will receive either the study drug or a placebo pill. The main goal is to measure how well they can stay awake during the day after 12 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alkermes Investigational Site
RECRUITINGCincinnati, Ohio, 45245, United States
-
Alkermes Investigational Site
RECRUITINGSugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.